SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-21-000094
Filing Date
2021-11-12
Accepted
2021-11-12 07:01:07
Documents
51
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q siox-20210930.htm   iXBRL 10-Q 1257523
2 EX-10.1 a09302110qsioxexhibit101.htm EX-10.1 196590
3 EX-31.1 a09302110qsioxexhibit311.htm EX-31.1 10871
4 EX-31.2 a09302110qsioxexhibit312.htm EX-31.2 11023
5 EX-32.1 a09302110qsioxexhibit321.htm EX-32.1 6950
6 EX-32.2 a09302110qsioxexhibit322.htm EX-32.2 6950
  Complete submission text file 0001636050-21-000094.txt   4392309

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20210930.xsd EX-101.SCH 26136
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20210930_cal.xml EX-101.CAL 38668
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20210930_def.xml EX-101.DEF 126340
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20210930_lab.xml EX-101.LAB 363814
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20210930_pre.xml EX-101.PRE 224116
12 EXTRACTED XBRL INSTANCE DOCUMENT siox-20210930_htm.xml XML 422319
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 211399452
SIC: 2834 Pharmaceutical Preparations